thirty-seven patients with advanced or recurrent lung cancer were randomized to cytoxan ( ctx ) alone , comf ( ctx , oncovin , methotrecate and 5-fu ) or amcof ( adriamycin , methotrexate , ctx , oncovin and 5-fu ) after receiving radiation therapy to primary and bulky tumor sites .
C0056159
comf
C0016360
5-fu